Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult

Journal of Immunology

Volumn 192, Issue 10, 2014, Pages 4551-4559

  Fiskesund, Roland ^a   Steen, Johanna ^a   Amara, Khaled ^a   Murray, Fiona ^a   Szwajda, Agnieszka ^b   Liu, Anquan ^a   Douagi, Iyadh ^a   Malmström, Vivianne ^a   Frostegard, Johan ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HAPTEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHORYLCHOLINE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CD27+ CD43+ B LYMPHOCYTE; CD27+ MEMORY B CELL; CONTROLLED STUDY; DH GENE; DONOR; FLOW CYTOMETRY; FLUORESCENCE; GENE; HUMAN; HUMAN CELL; JH GENE; JL GENE; MEMORY CELL; NORMAL HUMAN; PRIORITY JOURNAL; SOMATIC MUTATION; SURFACE PLASMON RESONANCE; VH GENE; VL GENE;

ADULT; ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; B-LYMPHOCYTE SUBSETS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; MALE; MICE; PHOSPHORYLCHOLINE;

EID: 84901282774     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303035     Document Type: Article

References (38)

1. Shaw, P. X., S. Hölrkköl , M. K. Chang, L. K. Curtiss, W. Palinski, G. J. Silverman, and J. L. Witztum. 2000. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105: 1731-1740.
2. Scott, M. G., D. E. Briles, P. G. Shackelford, D. S. Smith, and M. H. Nahm. 1987. Human antibodies to phosphocholine. IgG anti-PC antibodies express restricted numbers of V and C regions. J. Immunol. 138: 3325-3331.
3. Nishinarita, S., S. Sawada, and T. Horie. 1990. Phosphorylcholine antibodies in pulmonary infection. Med. Microbiol. Immunol. (Berl.) 179: 205-214.
4. Binder, C. J., M. K. Chang, P. X. Shaw, Y. I. Miller, K. Hartvigsen, A. Dewan, and J. L. Witztum. 2002. Innate and acquired immunity in atherogenesis. Nat. Med. 8: 1218-1226.
5. Binder, C. J., K. Hartvigsen, M. K. Chang, M. Miller, D. Broide, W. Palinski, L. K. Curtiss, M. Corr, and J. L. Witztum. 2004. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114: 427-437.
6. Chang, M. K., C. J. Binder, Y. I. Miller, G. Subbanagounder, G. J. Silverman, J. A. Berliner, and J. L. Witztum. 2004. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200: 1359-1370.
7. Goldenberg, H. B., T. L. McCool, and J. N. Weiser. 2004. Cross-reactivity of human immunoglobulin G2 recognizing phosphorylcholine and evidence for protection against major bacterial pathogens of the human respiratory tract. J. Infect. Dis. 190: 1254-1263.
8. Chou, M. Y., K. Hartvigsen, L. F. Hansen, L. Fogelstrand, P. X. Shaw, A. Boullier, C. J. Binder, and J. L. Witztum. 2008. Oxidation-specific epitopes are important targets of innate immunity. J. Intern. Med. 263: 479-488.
9. Hartvigsen, K., M. Y. Chou, L. F. Hansen, P. X. Shaw, S. Tsimikas, C. J. Binder, and J. L. Witztum. 2009. The role of innate immunity in atherogenesis. J. Lipid Res. 50(Suppl.): S388-S393.
10. Binder, C. J., P. X. Shaw, M. K. Chang, A. Boullier, K. Hartvigsen, S. Hölrkköl, Y. I. Miller, D. A. Woelkers, M. Corr, and J. L. Witztum. 2005. The role of natural antibodies in atherogenesis. J. Lipid Res. 46: 1353-1363.
11. Faria-Neto, J. R., K. Y. Chyu, X. Li, P. C. Dimayuga, C. Ferreira, J. Yano, B. Cercek, and P. K. Shah. 2006. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis 189: 83-90.
12. Caligiuri, G., J. Khallou-Laschet, M. Vandaele, A. T. Gaston, S. Delignat, C. Mandet, H. V. Kohler, S. V. Kaveri, and A. Nicoletti. 2007. Phosphorylcholinetargeting immunization reduces atherosclerosis. J. Am. Coll. Cardiol. 50: 540-546.
13. Binder, C. J., S. Hölrkköl, A. Dewan, M. K. Chang, E. P. Kieu, C. S. Goodyear, P. X. Shaw,W. Palinski, J. L.Witztum, and G. J. Silverman. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9: 736-743.
14. de Faire, U., J. Su, X. Hua, A. Frostegard, M. Halldin, M. L. Hellenius, M. Wikströlm, I. Dahlbom, H. Grölnlund, and J. Frostegard. 2010. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism. J. Autoimmun. 34: 73-79.
15. Grölnlund, H., G. Hallmans, J. H. Jansson, K. Boman, M. Wikströlm, U. de Faire, and J. Frostegard. 2009. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden. Eur. J. Cardiovasc. Prev. Rehabil. 16: 382-386.
16. Fiskesund, R., B. Stegmayr, G. Hallmans, M. Vikströlm, L. Weinehall, U. de Faire, and J. Frostegard. 2010. Low levels of antibodies against phosphorylcholine predict development of stroke in a population-based study from northern Sweden. Stroke 41: 607-612.
17. Caidahl, K., M. Hartford, T. Karlsson, J. Herlitz, K. Pettersson, U. de Faire, and J. Frostegard. 2013. IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes. Int. J. Cardiol. 167: 464-469.
18. Su, J., A. Georgiades, R. Wu, T. Thulin, U. de Faire, and J. Frostegard. 2006. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis 188: 160-166.
19. Mi, Q. S., L. Zhou, D. H. Schulze, R. T. Fischer, A. Lustig, L. J. Rezanka, D. M. Donovan, D. L. Longo, and J. J. Kenny. 2000. Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. Proc. Natl. Acad. Sci. USA 97: 6031-6036.
20. Tiller, T., E. Meffre, S. Yurasov, M. Tsuiji, M. C. Nussenzweig, and H. Wardemann. 2008. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329: 112-124.
21. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377.
22. Griffin, D. O., N. E. Holodick, and T. L. Rothstein. 2011. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+CD43+CD70-. J. Exp. Med. 208: 67-80.
23. Shlomchik, M. J., A. Marshak-Rothstein, C. B. Wolfowicz, T. L. Rothstein, and M. G. Weigert. 1987. The role of clonal selection and somatic mutation in autoimmunity. Nature 328: 805-811.
24. Defrance, T., M. Taillardet, and L. Genestier. 2011. T cell-independent B cell memory. Curr. Opin. Immunol. 23: 330-336.
25. Agathangelidis, A., N. Darzentas, A. Hadzidimitriou, X. Brochet, F. Murray, X. J. Yan, Z. Davis, E. J. van Gastel-Mol, C. Tresoldi, C. C. Chu, et al. 2012. Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 119: 4467-4475.
26. Amara, K., J. Steen, F. Murray, H. Morbach, B. M. Fernandez-Rodriguez, V. Joshua, M. Engströlm, O. Snir, L. Israelsson, A. I. Catrina, et al. 2013. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J. Exp. Med. 210: 445-455.
27. Gearhart, P. J., N. D. Johnson, R. Douglas, and L. Hood. 1981. IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts. Nature 291: 29-34.
28. Kim, S., M. Davis, E. Sinn, P. Patten, and L. Hood. 1981. Antibody diversity: somatic hypermutation of rearranged VH genes. Cell 27: 573-581.
29. Early, P., H. Huang, M. Davis, K. Calame, and L. Hood. 1980. An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell 19: 981-992.
30. Chen, Y., Y. B. Park, E. Patel, and G. J. Silverman. 2009. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol. 182: 6031-6043.
31. Weller, S., M. C. Braun, B. K. Tan, A. Rosenwald, C. Cordier, M. E. Conley, A. Plebani, D. S. Kumararatne, D. Bonnet, O. Tournilhac, et al. 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654.
32. Hammarströlm, L., M. A. Persson, and C. I. Smith. 1985. Immunoglobulin subclass distribution of human anti-carbohydrate antibodies: aberrant pattern in IgA-deficient donors. Immunology 54: 821-826.
33. Yang, Y., E. E. Ghosn, L. E. Cole, T. V. Obukhanych, P. Sadate-Ngatchou, S. N. Vogel, L. A. Herzenberg, and L. A. Herzenberg. 2012. Antigen-specific antibody responses in B-1a and their relationship to natural immunity. Proc. Natl. Acad. Sci. USA 109: 5382-5387.
34. Ueda, Y., D. Liao, K. Yang, A. Patel, and G. Kelsoe. 2007. T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells. J. Immunol. 178: 3593-3601.
35. Aranburu, A., S. Ceccarelli, E. Giorda, R. Lasorella, G. Ballatore, and R. Carsetti. 2010. TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells. J. Immunol. 185: 7293-7301.
36. Herlands, R. A., S. R. Christensen, R. A. Sweet, U. Hershberg, and M. J. Shlomchik. 2008. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity 29: 249-260.
37. Ajeganova, S., R. Fiskesund, U. de Faire, I. Hafströlm, and J. Frostegard. 2011. Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study. Clin. Exp. Rheumatol. 29: 942-950.
38. Ansel, K. M., R. B. Harris, and J. G. Cyster. 2002. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16: 67-76.